Our Science Impacts Lives

Science and innovation are the lifeblood of our company. But we’re doing more than developing medicines that perform well in the lab—we’re elevating the current standard of care to bring greater benefits to our patients.

482 million

patients living with conditions that our pipeline aims to treat, from cancer and Alzheimer’s disease to chronic immune-mediated conditions

Therapeutic Focus Areas

Researching Areas of Unmet Medical Need

We’re constantly finding new ways to address patients’ most serious health issues. We concentrate our efforts on a core set of therapeutic areas—ones where we’ve proven our expertise, and where we feel we can have an even greater impact on disease and how it is managed.

Where We Operate

Eight State-of-the-Art R&D Centers:

Lake County, Illinois, US
Redwood City, California, US
Sunnyvale, California, US (Pharmacyclics)
South San Francisco, California, US
Cambridge, Massachusetts, US
Worcester, Massachusetts, US
Ludwigshafen, Germany
Tokyo, Japan

Drug Development Process

From discovery to clinical trials to regulatory approval, learn more about the journey to bring a new therapy to patients.

A close up female scientist wearing goggles and building a prototype.
Technologies and Platforms

Bringing Better Solutions to Patients

By investing in groundbreaking technologies and platforms, our goal is to drive innovation within our pipeline and deliver better solutions to patients.

An up close image of a microscope eyepeice.

Devoted to New Discoveries

Our scientists are advancing a pipeline of specialty medicines with a focus on cancer, immune-mediated conditions, neurodegenerative diseases and more.

Four test tubes filled with blue liquid.
Our Products

A Portfolio of Medicines

We aim to develop innovative therapies for health conditions where there is significant need. Our medicines are approved in individual countries for different uses around the globe.